China’s drug regulator clears wave of home-grown innovative medicines amid biotech boom (opens in new tab)

Home-grown innovative drugs make up most of the medicines China’s drug regulator has approved for sale so far this year, underscoring the country’s biotech boom. Of the 19 innovative drugs cleared by the National Medical Products Administration (NMPA), 15 came from domestic companies, according to the regulator’s website as of May 21. These include sonrotoclax, […] The post appeared first on <a href="